Search
for
Sort by
Research 331–360 of 353
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- THE VICIOUS CYCLE OF POLYCYSTIC OVARY SYNDROME AND BINGE EATING DISORDER: A REVIEW OF METABOLIC, PSYCHOLOGICAL, AND IATROGENIC PATHWAYS
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Aesthetically relevant symptoms of menopause transition: Impact and approach to management
- Physiology of Skin, Hair, and Nails as Differentiated by Sex and Age
- Polycystic ovary syndrome: pragmatic management across levels of care
- Androgenetic alopecia
- Comparative Analysis of Differential Metabolites in <i>Panax quinquefolius</i> From China and the United States Using UPLC‐Orbitrap‐MS and LC‐MS/MS
- Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus
- Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) from a Young Age Due to a Rare Genetic Disorder, Familial Partial Lipodystrophy: A Case Report and Review of the Literature
- Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease
- Editorial: Untangle the broad connections and tight interactions between human microbiota and complex diseases through data-driven approaches, volume II
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Importance of dietary supplementation of soluble and insoluble fibers to sows subjected to high ambient temperatures during late gestation and effects on lactation performance
- Is polymorphism of the STK11 gene a predictor of response to metformin in polycystic ovarian syndrome?
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Assessment of Multidimensional Health Care Parameters Among Adults in Japan for Developing a Virtual Human Generative Model: Protocol for a Cross-sectional Study
- STUDY OF FECAL GLUCOCORTICOID METABOLITE IN BEARS: A REVIEW
- Oral Presentation Abstracts
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- Neuroendokrine paraneoplastische Syndrome
- ZALCITABINE
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms
- Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review